http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020106825-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_226bafeb49afdadf295028c39ade5c42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ca2fe5a1e9022aa0323cbb48d30f5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08059502d19aac54dcdfa5b2013ed8ba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b717368476ec662450751f27fc8d3e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0471e195f4052424d4c4b60302d0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae49da09ab2581da76550920df417746
publicationDate 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020106825-A1
titleOfInvention Compositions and methods for treating neurodegenerative, myodegenerative, and lysosomal storage disorders
abstract Provided herein are compositions and methods for treating or preventing a neurodegenerative disease, a myodegenerative disease, a prion disease or a lysosomal storage disease in a subject.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155427-A1
priorityDate 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017158706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007099941-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73762775

Total number of triples: 37.